Rare condition

Typhoid

ORPHA:99745 ↗

Search all Typhoid trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

2 Jan 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 4NCT03705585

CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera

Sponsor University of Maryland, BaltimoreWhere United States (1 site)Studying Vivotif Typhoid Oral Vaccine, VaxchoraUpdated 4 Sept 2026

See details

RecruitingPhase 4NCT07314281

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

Sponsor Indus Hospital and Health NetworkWhere Pakistan (1 site)Studying Azithromycin, Meropenem InjectionUpdated 8 May 2026

See details

RecruitingPhase 2NCT07286370

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

Sponsor GlaxoSmithKlineWhere The Gambia (1 site)Studying Low dose of iNTS-TCV, Full dose of iNTS-TCVUpdated 20 Apr 2026

See details

RecruitingPhase 4NCT03971669

Blood Donor CVD 5000

Sponsor University of Maryland, BaltimoreWhere United States (1 site)Studying Vivotif Typhoid Oral VaccineUpdated 27 Mar 2026

See details

RecruitingNCT04878549

Transcriptomic Responses for the Identification of Pathogens

Sponsor University of SheffieldWhere India (1 site)Studying 5-gene transcription signatureUpdated 3 Mar 2025

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Typhoid studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

India Pakistan The Gambia United States

Keep watching

Get an email when a new Typhoid study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:99745 ↗

About Typhoid

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

2 approved treatments and 4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Ciprofloxacin (Cetraxal)Approved: Levofloxacin (Evoxil)

Phase 1/2Tetanus Toxoid (Equilis te)

Phase 1Salmonella Typhi Ty2 Vi Polysaccharide Antigen

INDNalidixic Acid (Mictral)

INDAmpicillin (Amcill)

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).